Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 84.03M | $ 73.20M | $ 97.06M | $ 80.60M | $ 86.38M |
Total Assets | $ 165.48M | $ 145.14M | $ 162.14M | $ 149.54M | $ 141.34M |
Total Debt | $ 13.96M | $ 14.72M | $ 15.59M | $ 15.70M | $ 16.34M |
Net Debt | $ -70.07M | $ -58.49M | $ -81.47M | $ -64.90M | $ -70.04M |
Total Liabilities | $ 32.09M | $ 29.29M | $ 31.43M | $ 31.59M | $ 31.87M |
Stockholders Equity | $ 133.39M | $ 115.85M | $ 130.71M | $ 117.94M | $ 109.47M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |